Jun 22, 2020
Regeneron Announces the 2020 Winners of the Regeneron Prize for Creative Innovation
May 13, 2020
Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio
Apr 08, 2020
Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)
Mar 16, 2020
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
Nov 06, 2019
Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer
Mar 12, 2019
Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2019 with Innovative Ideas on Exoplanets, HIV and a Classic Math Problem
Jan 23, 2019
Forty of the Nation's Most Brilliant Young Scientists Named Finalists in Regeneron Science Talent Search 2019
Jan 07, 2019
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
Dec 01, 2018
Regeneron Presents Positive Data at ASH for REGN1979 CD20xCD3 Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Oct 08, 2018
Libtayo® (cemiplimab-rwlc) Data at ESMO 2018 Congress Provide New Insights in Six Tumor Types Under Investigation
Aug 03, 2018
Regeneron Announces the 2018 Winners of the Regeneron Prize for Creative Innovation
Mar 10, 2018
Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need
Mar 10, 2018
Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need
Mar 02, 2018
FDA to Review DUPIXENT® (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Feb 12, 2018
Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial
Feb 08, 2018
Regeneron Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
Jan 23, 2018
Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018
Jan 23, 2018
Regeneron to Report Fourth Quarter and Full Year 2017 Financial and Operating Results and Host Conference Call and Webcast on February 8, 2018
Jan 22, 2018
Regeneron Announces Approval of DUPIXENT® (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Jan 08, 2018
Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs